Evidence map›Paper›PMID 25981400›Full record

ArticleWorld journal of urology2016

Involvement of renin-angiotensin-aldosterone system in calcium oxalate crystal induced activation of NADPH oxidase and renal cell injury.

Hidenori Tsuji, Wei Wang, Joshi Sunil, Nobutaka Shimizu, Kazuhiro Yoshimura, Hirotsugu Uemura, Ammon B Peck, Saeed R Khan

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of urology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Vitamin D and calcium kidney stones: a review and a proposal.International urology and nephrology · 2019
    Review
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Hidenori TsujiDepartment of Urology, Faculty of Medicine, Kinki University, 377-2 Ohnohigashi, Osakasayama, Osaka, 589-8511, Japan.
Wei WangDepartment of Pathology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
Joshi SunilDepartment of Pathology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
Nobutaka ShimizuDepartment of Urology, Faculty of Medicine, Kinki University, 377-2 Ohnohigashi, Osakasayama, Osaka, 589-8511, Japan. nsimizu810@yahoo.co.jp.
Kazuhiro YoshimuraDepartment of Urology, Faculty of Medicine, Kinki University, 377-2 Ohnohigashi, Osakasayama, Osaka, 589-8511, Japan.
Hirotsugu UemuraDepartment of Urology, Faculty of Medicine, Kinki University, 377-2 Ohnohigashi, Osakasayama, Osaka, 589-8511, Japan.
Ammon B PeckDepartment of Pathology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
Saeed R KhanDepartment of Pathology and Laboratory Medicine, College of Medicine, University of Florida, Gainesville, FL, USA.
University of Florida · USKindai University · JP

Funding

Crystal Associated Renal Inflammation and Treatment OptionsR01DK078602 · NIDDK · UNIVERSITY OF FLORIDA · PI KHAN, SAEED R. · 2009 to 2012
$1.3M
NIDDK NIH HHS R01 DK078602NIDDK NIH HHS R01-DK078602
6 · The paper itself

Abstract

INTRODUCTION AND

objectivesReactive oxygen species (ROS) are produced during the interaction between oxalate/calcium oxalate monohydrate (COM) crystals and renal epithelial cells and are responsible for the various cellular responses through the activation of NADPH oxidase (Nox). Ox and COM also activate the renin-angiotensin-aldosterone system (RAAS). Aldosterone stimulates ROS production through activation of Nox with the involvement of mineralocorticoid receptor (MR), Rac1 and mitogen-activated protein kinases (MAPK). We investigated RAAS pathways in vivo in an animal model of hyperoxaluria and in vitro by exposing renal epithelial cells to COM crystals.

methodsHyperoxaluria was induced in male SD rats by administering ethylene glycol. One group of rats was additionally given spironolactone. Total RNA was extracted and subjected to genomic microarrays to obtain global transcriptome data. Normal rat kidney cell line (NRK-52E) was incubated with aldosterone(10(-7) M) and COM(67 μg/cm(2)) with or without spironolactone(10(-5) M), a selective inhibitor of SRC family of kinases; protein phosphatase 2(pp2) (10(-5) M) and Nox inhibitor; diphenylene iodonium (DPI) (10(-5) M).

resultsRelative expression of genes encoding for AGT, angiotensin receptors 1b and 2, Renin 1, Cyp11b, HSD11B2, Nr3c2, NOx4 and Rac1 was upregulated in the kidneys of rats with hyperoxaluria. Treatment with spironolactone reversed the effect of hyperoxaluria. Both aldosterone and COM crystals activated Nox and Rac1 expression in NRK52E, while spironolactone inhibited Nox and Rac1 expression. Increased Rac1 expression was significantly attenuated by treatment with PP2 and spironolactone.

conclusionsResults indicate that hyperoxaluria-induced production of ROS, injury and inflammation are in part associated with the activation of Nox through renin-angiotensin-aldosterone pathway.

Indexed as

11-beta-Hydroxysteroid Dehydrogenase Type 2AngiotensinogenAnimalsCalcium OxalateCell LineCytochrome P-450 CYP11B2Disease Models, AnimalEnzyme InhibitorsEthylene GlycolGene Expression ProfilingHyperoxaluriaMaleMineralocorticoid Receptor AntagonistsNADPH Oxidase 4NADPH OxidasesOnium Compounds11-beta-Hydroxysteroid Dehydrogenase Type 2Agt protein, ratAngiotensinogenCalcium OxalateCytochrome P-450 CYP11B2diphenyleneiodoniumEnzyme InhibitorsEthylene GlycolMineralocorticoid Receptor AntagonistsNADPH Oxidase 4NADPH OxidasesNox4 protein, ratOnium CompoundsProtein Phosphatase 2rac1 GTP-Binding ProteinRac1 protein, ratReceptors, AngiotensinReceptors, MineralocorticoidReninRNA, MessengerSpironolactoneSteroid 11-beta-HydroxylaseAldosteroneMineralcorticoid receptorNADPH oxidaseRac1Spironolactone

Identifiers

PMID25981400
OpenAlexW252474447

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.